Barclays’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$193K Sell
13,786
-56,152
-80% -$757K ﹤0.01% 3711
2025
Q4
$785K Buy
69,938
+5,856
+9% +$67K ﹤0.01% 3594
2025
Q3
$741K Sell
64,082
-20,090
-24% -$235K ﹤0.01% 3554
2025
Q2
$1.03M Buy
84,172
+25,459
+43% +$320K ﹤0.01% 3317
2025
Q1
$841K Sell
58,713
-21,488
-27% -$335K ﹤0.01% 3208
2024
Q4
$1.28M Sell
80,201
-15,993
-17% -$317K ﹤0.01% 3212
2024
Q3
$2.31M Buy
96,194
+78,583
+446% +$1.8M ﹤0.01% 2744
2024
Q2
$351K Sell
17,611
-28,958
-62% -$564K ﹤0.01% 3257
2024
Q1
$927K Sell
46,569
-44,832
-49% -$867K ﹤0.01% 3173
2023
Q4
$2.05M Buy
91,401
+52,359
+134% +$1.08M ﹤0.01% 2897
2023
Q3
$789K Buy
39,042
+7,646
+24% +$173K ﹤0.01% 2498
2023
Q2
$802K Sell
31,396
-4,516
-13% -$119K ﹤0.01% 2453
2023
Q1
$1.07M Buy
35,912
+6,037
+20% +$175K ﹤0.01% 2683
2022
Q4
$808K Sell
29,875
-5,172
-15% -$126K ﹤0.01% 2974
2022
Q3
$763K Buy
35,047
+12,732
+57% +$333K ﹤0.01% 2416
2022
Q2
$610K Sell
22,315
-31,816
-59% -$914K ﹤0.01% 2726
2022
Q1
$1.81M Sell
54,131
-20,561
-28% -$662K ﹤0.01% 1940
2021
Q4
$2.59M Buy
74,692
+19,563
+35% +$632K ﹤0.01% 2209
2021
Q3
$1.72M Buy
55,129
+17,623
+47% +$598K ﹤0.01% 2449
2021
Q2
$1.36M Sell
37,506
-8,258
-18% -$341K ﹤0.01% 2458
2021
Q1
$2M Buy
45,764
+26,837
+142% +$1.26M ﹤0.01% 2273
2020
Q4
$869K Sell
18,927
-13,907
-42% -$579K ﹤0.01% 2855
2020
Q3
$1.09M Sell
32,834
-2,703
-8% -$86.4K ﹤0.01% 2618
2020
Q2
$1.04M Sell
35,537
-31,317
-47% -$907K ﹤0.01% 2720
2020
Q1
$1.8M Sell
66,854
-35,400
-35% -$1.06M ﹤0.01% 2386
2019
Q4
$3.45M Buy
102,254
+77,759
+317% +$2.82M ﹤0.01% 2413
2019
Q3
$918K Sell
24,495
-13,042
-35% -$498K ﹤0.01% 3748
2019
Q2
$1.64M Sell
37,537
-46,143
-55% -$1.97M ﹤0.01% 3153
2019
Q1
$3.57M Buy
83,680
+41,136
+97% +$1.84M 0.01% 1967
2018
Q4
$1.91M Sell
42,544
-40,717
-49% -$2.13M ﹤0.01% 2459
2018
Q3
$5.7M Buy
83,261
+28,798
+53% +$1.85M 0.01% 1682
2018
Q2
$3.12M Buy
54,463
+34,106
+168% +$1.8M 0.01% 2140
2018
Q1
$938K Buy
20,357
+5,014
+33% +$238K ﹤0.01% 3294
2017
Q4
$709K Buy
15,343
+13,532
+747% +$622K ﹤0.01% 3460
2017
Q3
$83K Sell
1,811
-19,070
-91% -$814K ﹤0.01% 5048
2017
Q2
$820K Sell
20,881
-5,227
-20% -$198K ﹤0.01% 3050
2017
Q1
$993K Sell
26,108
-36,441
-58% -$1.42M ﹤0.01% 2745
2016
Q4
$2.31M Sell
62,549
-15,230
-20% -$544K 0.01% 2003
2016
Q3
$2.7M Buy
77,779
+43,860
+129% +$1.54M 0.01% 1745
2016
Q2
$1.1M Sell
33,919
-8,618
-20% -$264K ﹤0.01% 2529
2016
Q1
$1.19M Buy
42,537
+29,437
+225% +$784K ﹤0.01% 2384
2015
Q4
$433K Buy
13,100
+12,096
+1,205% +$376K ﹤0.01% 3319
2015
Q3
$29K Sell
1,004
-64,855
-98% -$2.26M ﹤0.01% 5294
2015
Q2
$2.63M Buy
65,859
+64,737
+5,770% +$2.91M 0.01% 1999
2015
Q1
$55K Sell
1,122
-6,174
-85% -$286K ﹤0.01% 5207
2014
Q4
$328K Buy
+7,296
New +$287K ﹤0.01% 4234

Other funds holding AVNS